Clinical Trials Directory

Trials / Completed

CompletedNCT04040946

Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention

Phase III Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Centre Francois Baclesse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that positron emission tomography with fluorocholline (F18-choline PET) will reduce the proportion of unnecessary invasive surgery decisions and that the higher cost of positron emission tomography versus MIBI scintigraphy (Tc99m-sestaMIBI ) will be offset by lower cost in terms of type. surgery performed wisely and complications.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMIBI scintigraphyPerforming a MIBI scintigraphy, then, in the case of negativity, a single F18-choline PET
DIAGNOSTIC_TESTF18-choline PETRealization of a F18-choline PET, then, in case of negativity, a MIBI scintigraphy

Timeline

Start date
2019-09-19
Primary completion
2022-05-05
Completion
2023-06-30
First posted
2019-08-01
Last updated
2023-08-01

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04040946. Inclusion in this directory is not an endorsement.

Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroid (NCT04040946) · Clinical Trials Directory